GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition – Hagens Berman

Impact · against what's priced in

GeneDx faces a significant valuation reset following a disastrous Q1 report characterized by a 94% write-off of the Fabric Genomics acquisition and slashed growth guidance. The subsequent securities class action lawsuit adds a layer of legal and regulatory risk to an already deteriorating operational profile.

WGS−0.90

No priced-in read yet